eporgen.com
Target Heart Biotech
http://www.eporgen.com/aziende/targetheart.asp
Originated from the University of Torino; established in 2005, it operates in the cardiovascular field. Two patents filed in 2002 and 2010. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload , De Acetis et al. (2005), Circulation Research, 96. Link: http:/ www.ncbi.nlm.nih.gov/pubmed/15860758. 2003) Nature Medicine, 9. Link: http:/ www.ncbi.nlm.nih.gov/pubmed/12496958. 2007) Eur. J. Heart Failure, 9. Pharmacokinetic tests (pre-clinical model in a...